CASE REPORT ON THE SUCCESSFUL USE OF A NEW SELECTIVE PROSTACYCLIN IP RECEPTOR AGONIST, SELEXIPAG, IN A PATIENT WITH IDIOPATHIC PULMONARY HYPERTENSION
Idiopathic pulmonary arterial hypertension (IPAH) is a rather rare cardiovascular disease of unknown origin and, at the same time, the most common form of pulmonary arterial hypertension (PAH). It is characterized by increased mean pulmonary artery pressure of ≥ 25 mm Hg and increased pulmonary vasc...
| Published in: | Евразийский Кардиологический Журнал |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
InterMedservice
2019-12-01
|
| Subjects: | |
| Online Access: | https://www.heartj.asia/jour/article/view/347 |